Adaptive Biotechnologies (ADPT) Interest & Investment Income (2018 - 2025)
Adaptive Biotechnologies (ADPT) has disclosed Interest & Investment Income for 8 consecutive years, with $2.1 million as the latest value for Q4 2025.
- Quarterly Interest & Investment Income fell 30.08% to $2.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.4 million through Dec 2025, down 35.02% year-over-year, with the annual reading at $9.4 million for FY2025, 35.02% down from the prior year.
- Interest & Investment Income hit $2.1 million in Q4 2025 for Adaptive Biotechnologies, down from $2.2 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $4.6 million in Q4 2023 to a low of $239000.0 in Q4 2021.
- Historically, Interest & Investment Income has averaged $2.3 million across 5 years, with a median of $2.5 million in 2022.
- Biggest five-year swings in Interest & Investment Income: tumbled 77.95% in 2021 and later surged 1015.87% in 2023.
- Year by year, Interest & Investment Income stood at $239000.0 in 2021, then surged by 988.7% to $2.6 million in 2022, then skyrocketed by 77.29% to $4.6 million in 2023, then plummeted by 33.41% to $3.1 million in 2024, then plummeted by 30.08% to $2.1 million in 2025.
- Business Quant data shows Interest & Investment Income for ADPT at $2.1 million in Q4 2025, $2.2 million in Q3 2025, and $2.4 million in Q2 2025.